ImmunoGen, Inc. Net Profit Margin 2010-2023 | IMGN
ImmunoGen, Inc. net profit margin from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
Net Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Net Income |
Net Margin |
2023-09-30 |
$0.29B |
$-0.07B |
-25.44% |
2023-06-30 |
$0.19B |
$-0.18B |
-96.30% |
2023-03-31 |
$0.12B |
$-0.24B |
-200.00% |
2022-12-31 |
$0.11B |
$-0.22B |
-206.48% |
2022-09-30 |
$0.10B |
$-0.20B |
-211.58% |
2022-06-30 |
$0.09B |
$-0.16B |
-179.78% |
2022-03-31 |
$0.09B |
$-0.13B |
-140.22% |
2021-12-31 |
$0.07B |
$-0.14B |
-198.57% |
2021-09-30 |
$0.13B |
$-0.07B |
-55.47% |
2021-06-30 |
$0.14B |
$-0.06B |
-40.88% |
2021-03-31 |
$0.14B |
$-0.05B |
-36.30% |
2020-12-31 |
$0.13B |
$-0.04B |
-33.33% |
2020-09-30 |
$0.09B |
$-0.07B |
-76.92% |
2020-06-30 |
$0.09B |
$-0.07B |
-81.40% |
2020-03-31 |
$0.09B |
$-0.09B |
-102.30% |
2019-12-31 |
$0.08B |
$-0.10B |
-125.30% |
2019-09-30 |
$0.05B |
$-0.15B |
-296.08% |
2019-06-30 |
$0.05B |
$-0.18B |
-359.18% |
2019-03-31 |
$0.04B |
$-0.18B |
-416.67% |
2018-12-31 |
$0.05B |
$-0.17B |
-320.75% |
2018-09-30 |
$0.08B |
$-0.14B |
-178.48% |
2018-06-30 |
$0.08B |
$-0.15B |
-198.68% |
2018-03-31 |
$0.11B |
$-0.12B |
-111.32% |
2017-12-31 |
$0.11B |
$-0.10B |
-84.21% |
2017-06-30 |
$0.08B |
$-0.07B |
-94.67% |
2017-03-31 |
$0.04B |
$-0.11B |
-251.16% |
2016-09-30 |
$0.05B |
$-0.16B |
-294.34% |
2016-06-30 |
$0.06B |
$-0.15B |
-241.67% |
2015-12-31 |
$0.04B |
$-0.09B |
-202.27% |
2015-09-30 |
$0.07B |
$-0.04B |
-56.76% |
2014-12-31 |
$0.07B |
$-0.05B |
-66.18% |
2014-09-30 |
$0.05B |
$-0.06B |
-110.00% |
2013-12-31 |
$0.07B |
$-0.01B |
-11.11% |
2013-09-30 |
$0.05B |
$-0.04B |
-80.00% |
2012-12-31 |
$0.01B |
$-0.07B |
-680.00% |
2012-09-30 |
$0.02B |
$-0.06B |
-380.00% |
2011-12-31 |
$0.02B |
$-0.05B |
-293.75% |
2011-09-30 |
$0.01B |
$-0.05B |
-400.00% |
2010-12-31 |
$0.01B |
$-0.04B |
-390.00% |
2010-09-30 |
$0.01B |
$-0.04B |
-422.22% |
2009-12-31 |
$0.01B |
$-0.03B |
-214.29% |